Bio-Rad Laboratories Inc. (BIO)
undefined
undefined%
At close: undefined
343.47
0.11%
After-hours Jan 06, 2025, 07:00 PM EST

Bio-Rad Laboratories Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012Mar 31, 2012Dec 31, 2011Sep 30, 2011Jun 30, 2011
Clinical Diagnostics Revenue 388.80M 368.60M 389.00M 368.10M 380.10M 352.10M 369.50M 361.90M 367.80M 351.80M 405.00M 372.20M 380.20M 358.50M 359.50M 322.20M 283.20M 340.30M 379.00M 341.80M 357.10M 334.10M 373.00M 334.00M 354.00M 350.80M 378.40M 338.00M 322.10M 322.30M 360.80M 327.10M 333.70M 301.70M 348.50M 316.20M 332.10M 313.60M 370.40M 354.70M 362.90M 344.30M 377.80M 338.80M 351.50M 339.90M 365.90M 328.40M 344.00M 327.20M 674.50M 341.30M 348.00M
Clinical Diagnostics Revenue Growth +5.48% -5.24% +5.68% -3.16% +7.95% -4.71% +2.10% -1.60% +4.55% -13.14% +8.81% -2.10% +6.05% -0.28% +11.58% +13.77% -16.78% -10.21% +10.88% -4.28% +6.88% -10.43% +11.68% -5.65% +0.91% -7.29% +11.95% +4.94% -0.06% -10.67% +10.30% -1.98% +10.61% -13.43% +10.22% -4.79% +5.90% -15.33% +4.43% -2.26% +5.40% -8.87% +11.51% -3.61% +3.41% -7.11% +11.42% -4.53% +5.13% -51.49% +97.63% -1.93% n/a
Life Science Revenue 260.90M 241.70M 291.10M 263.50M 300.20M 323.60M 359.70M 317.90M 322.40M 347.20M 326.60M 373.50M 334.20M 366.50M 428.50M 324.00M 252.10M 227.20M 242.10M 215.70M 212.40M 215.70M 239.50M 206.60M 217.80M 197.80M 237.90M 193.60M 179.40M 174.30M 206.70M 178.10M 180.00M 165.90M 218.10M 150.40M 170.60M 155.90M 223.70M 172.80M 170.30M 161.50M 220.40M 162.90M 170.40M 156.30M 204.20M 167.00M 162.40M 154.80M 353.30M 171.50M 169.90M
Life Science Revenue Growth +7.94% -16.97% +10.47% -12.23% -7.23% -10.04% +13.15% -1.40% -7.14% +6.31% -12.56% +11.76% -8.81% -14.47% +32.25% +28.52% +10.96% -6.15% +12.24% +1.55% -1.53% -9.94% +15.92% -5.14% +10.11% -16.86% +22.88% +7.92% +2.93% -15.67% +16.06% -1.06% +8.50% -23.93% +45.01% -11.84% +9.43% -30.31% +29.46% +1.47% +5.45% -26.72% +35.30% -4.40% +9.02% -23.46% +22.28% +2.83% +4.91% -56.18% +106.01% +0.94% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014
Americas Revenue 166.60M 155.40M 156.60M 136.60M 137.30M 138.30M 140.20M 128.30M 128.50M 150.90M
Americas Revenue Growth +7.21% -0.77% +14.64% -0.51% -0.72% -1.36% +9.28% -0.16% -14.84% n/a
Asia Pacific Revenue 563.00M 639.40M 688.40M 546.50M 505.00M 495.50M 461.30M 427.10M 392.20M 417.50M
Asia Pacific Revenue Growth -11.95% -7.12% +25.97% +8.22% +1.92% +7.41% +8.01% +8.90% -6.06% n/a
Europe Revenue 819.80M 851.90M 946.90M 857.70M 770.30M 792.00M 758.50M 742.20M 763.70M 901.70M
Europe Revenue Growth -3.77% -10.03% +10.40% +11.35% -2.74% +4.42% +2.20% -2.82% -15.30% n/a
United States Revenue 1.12B 1.16B 1.13B 1.00B 899.10M 863.60M 800.20M 770.60M 735.00M 704.90M
United States Revenue Growth -2.91% +2.20% +12.52% +11.76% +4.11% +7.92% +3.84% +4.84% +4.27% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 200.44M 196.12M 210.48M 205.90M 201.20M 207.82M 225.55M 212.23M 211.05M 208.73M 197.59M 224.15M 216.15M 213.43M 225.85M 219.15M 198.16M 189.26M 193.69M 214.16M 201.62M 201.26M 207.58M 212.54M 201.20M 210.43M 209.13M 204.21M 196.77M 213.03M 194.94M 220.02M 201.45M 205.54M 189.72M 193.15M 187.44M 192.84M 188.56M
Selling, General, and Administrative Revenue Growth +2.20% -6.82% +2.23% +2.33% -3.19% -7.86% +6.28% +0.56% +1.11% +5.64% -11.85% +3.70% +1.28% -5.50% +3.06% +10.59% +4.70% -2.29% -9.56% +6.22% +0.18% -3.05% -2.33% +5.64% -4.39% +0.62% +2.41% +3.78% -7.63% +9.28% -11.40% +9.22% -1.99% +8.34% -1.78% +3.04% -2.80% +2.28% n/a
Research and Development Revenue 91.00M 59.30M 63.98M 62.21M 43.53M 65.04M 74.95M 66.20M 69.95M 67.03M 62.54M 69.87M 64.48M 63.39M 73.91M 65.77M 59.55M 51.98M 49.30M 57.07M 47.94M 50.12M 47.58M 53.07M 49.24M 47.45M 49.43M 76.82M 61.37M 62.62M 49.49M 57.54M 49.92M 52.17M 48.59M 55.89M 43.34M 46.55M 47.20M
Research and Development Revenue Growth +53.44% -7.30% +2.83% +42.90% -33.07% -13.22% +13.22% -5.36% +4.35% +7.18% -10.49% +8.36% +1.72% -14.23% +12.39% +10.44% +14.55% +5.44% -13.61% +19.03% -4.35% +5.35% -10.36% +7.78% +3.78% -4.00% -35.66% +25.17% -2.00% +26.54% -14.00% +15.26% -4.31% +7.38% -13.06% +28.96% -6.90% -1.39% n/a

Create Price Alert on BIO

Your price alert will notify you when the stock price is above 343.10.

Add to Watchlist